A D1 Agonist For Working Memory

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

January 12, 2018

Study Completion Date

January 12, 2018

Conditions
Schizotypal Personality DisorderSPD
Interventions
DRUG

DAR 0-100A

15 mg DAR 0100A is dissolved in 150 cc NS administered over 30 minutes intravenously.

DRUG

Placebo

15 mg DAR placebo is dissolved in 150 cc NS administered over 30 minutes intravenously.

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
collaborator

New York State Psychiatric Institute

OTHER

collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Antonia New

OTHER

NCT02507206 - A D1 Agonist For Working Memory | Biotech Hunter | Biotech Hunter